Ghent to Use Roche's LightCycler in Cancer Studies | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Scientists at Ghent University in Belgium will use Roche's LightCycler 1536 in various cancer research projects, the company said today.

Ghent researchers will use the technology for multi-gene expression signature profiling on cancer research samples and for digital PCR for sensitive detection of mutant cancer cells in a background of normal cells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.